Emyria
About
What does Emyria do?
Emyria is an ASX-listed, data-backed drug development and care delivery company focused on unmet needs in mental health and neurological conditions. They combine frontline care with clinical research and real-world data to develop new therapies and breakthrough treatments, including psychedelic-assisted therapies and cannabinoid-based medicines. Emyria operates a network of specialist medical clinics and uses proprietary clinical evidence to accelerate drug development and registration.
Where is Emyria headquartered?
Emyria is headquartered in Perth, Australia.
When was Emyria founded?
Emyria was founded in 2019.
What industry does Emyria operate in?
Emyria operates in HealthTech, Biotech, Drug Discovery, Clinical Trials, Mental Health Tech, Psychedelic-Assisted Therapy.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.